BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 9806485)

  • 1. An overview of anti-Hepatitis B virus flavonoids and their mechanisms of action.
    Naderi M; Salavatiha Z; Gogoi U; Mohebbi A
    Front Cell Infect Microbiol; 2024; 14():1356003. PubMed ID: 38487354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An
    Biswas S; Mita MA; Afrose S; Hasan MR; Shimu MSS; Zaman S; Saleh MA
    Heliyon; 2024 Feb; 10(4):e25837. PubMed ID: 38379969
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel anti-hepatitis B virus-active catechin and epicatechin from
    Parvez MK; Al-Dosari MS; Abdelwahid MAS; Alqahtani AS; Alanzi AR
    Exp Ther Med; 2022 Jun; 23(6):398. PubMed ID: 35619632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-hepatitis B virus and anti-hepatotoxic efficacies of solanopubamine, a rare alkaloid from
    Parvez MK; Al-Dosari MS; Rehman MT; Al-Rehaily AJ; Alqahtani AS; Alajmi MF
    Saudi Pharm J; 2022 Apr; 30(4):359-368. PubMed ID: 35527834
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytomedicines to Target Hepatitis B Virus DNA Replication: Current Limitations and Future Approaches.
    Sadiea RZ; Sultana S; Chaki BM; Islam T; Dash S; Akter S; Islam MS; Kazi T; Nagata A; Spagnuolo R; Mancina RM; Hossain MG
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the efficacy of naturally occurring biflavone based antioxidants towards the inhibition of the SARS-CoV-2 spike glycoprotein mediated membrane fusion.
    Mondal S; Karmakar A; Mallick T; Begum NA
    Virology; 2021 Apr; 556():133-139. PubMed ID: 33571798
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biflavonoids from
    Lokhande K; Nawani N; K Venkateswara S; Pawar S
    J Biomol Struct Dyn; 2022 Jul; 40(10):4376-4388. PubMed ID: 33300454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular docking, validation, dynamics simulations, and pharmacokinetic prediction of natural compounds against the SARS-CoV-2 main-protease.
    C S; S DK; Ragunathan V; Tiwari P; A S; P BD
    J Biomol Struct Dyn; 2022 Feb; 40(2):585-611. PubMed ID: 32897178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, Synthesis and Bioactive Evaluation of Oxime Derivatives of Dehydrocholic Acid as Anti-Hepatitis B Virus Agents.
    Wei Z; Tan J; Cui X; Zhou M; Huang Y; Zang N; Chen Z; Wei W
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32722086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naturally derived anti-hepatitis B virus agents and their mechanism of action.
    Wu YH
    World J Gastroenterol; 2016 Jan; 22(1):188-204. PubMed ID: 26755870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of the hydroethanolic extract and biflavonoids isolated from Selaginella sellowii on Leishmania (Leishmania) amazonensis.
    Rizk YS; Fischer A; Cunha Mde C; Rodrigues PO; Marques MC; Matos Mde F; Kadri MC; Carollo CA; Arruda CC
    Mem Inst Oswaldo Cruz; 2014 Dec; 109(8):1050-6. PubMed ID: 25591109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery and development of anti-HBV agents and their resistance.
    Kim KH; Kim ND; Seong BL
    Molecules; 2010 Aug; 15(9):5878-908. PubMed ID: 20802402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An experiment on standardized cell culture assay in assessing the activities of Composite Artemisia Capillaris Tablets against hepatitis B virus replication in vitro.
    Han J; Zhao YL; Shan LM; Huang FJ; Xiao XH
    Chin J Integr Med; 2005 Mar; 11(1):54-6. PubMed ID: 15975310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination chemotherapy for hepatitis B virus: the path forward?
    Shaw T; Locarnini S
    Drugs; 2000 Sep; 60(3):517-31. PubMed ID: 11030464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lamivudine. A review of its therapeutic potential in chronic hepatitis B.
    Jarvis B; Faulds D
    Drugs; 1999 Jul; 58(1):101-41. PubMed ID: 10439933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Robustaflavone, a potential non-nucleoside anti-hepatitis B agent.
    Zembower DE; Lin YM; Flavin MT; Chen FC; Korba BE
    Antiviral Res; 1998 Aug; 39(2):81-8. PubMed ID: 9806485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penciclovir is a selective inhibitor of hepatitis B virus replication in cultured human hepatoblastoma cells.
    Korba BE; Boyd MR
    Antimicrob Agents Chemother; 1996 May; 40(5):1282-4. PubMed ID: 8723485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiviral activities of biflavonoids.
    Lin YM; Flavin MT; Schure R; Chen FC; Sidwell R; Barnard DL; Huffman JH; Kern ER
    Planta Med; 1999 Mar; 65(2):120-5. PubMed ID: 10193201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of stable cell lines expressing Lamivudine-resistant hepatitis B virus for antiviral-compound screening.
    Walters KA; Tipples GA; Allen MI; Condreay LD; Addison WR; Tyrrell L
    Antimicrob Agents Chemother; 2003 Jun; 47(6):1936-42. PubMed ID: 12760870
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.